Membrane Oxygenators Market Trends

Membrane Oxygenators Market Trends

The rising prevalence of cardiovascular diseases (CVDs) is a significant driver of the global membrane oxygenators industry. CVDs, including coronary artery disease, heart failure, and myocardial infarction, have become leading causes of mortality worldwide. According to the World Health Organization (WHO), an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths, with an increasing incidence in both developed and developing countries.
 

• This surge in CVD cases necessitates the adoption of advanced medical technologies, such as membrane oxygenators, to support patients requiring extracorporeal membrane oxygenation (ECMO) therapy. Membrane oxygenators play a crucial role in oxygenating blood and removing carbon dioxide during cardiac surgeries, organ transplants, and emergency interventions like cardiogenic shock, thereby improving patient survival and recovery.
   
• The growing demand for life-supporting interventions in cardiac care, especially during high-risk surgeries or in critical conditions such as acute myocardial infarction and post-transplant complications, further fuels market growth.
   
• Additionally, increasing healthcare investments and the expansion of advanced cardiac care infrastructure are facilitating wider access to these essential life-saving devices.